Corinne Brunet-Nicolino

Laboratoire D'Hématologie Et Biologie Vasculaire Du Pr Françoise Dignat George
Marseille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Multicentric MFI30 study: Standardization of flow cytometry analysis of CD30 expression in non-Hodgkin lymphoma.

Multicentric MFI30 study: Standardization of flow cytometry analysis of CD30 expression in non-Hodgkin lymphoma.

Journal: Cytometry. Part B, Clinical cytometry

Published: March 06, 2020

Mathematical modeling of peripheral blood neutrophil kinetics to predict CLAD after lung transplantation.

Mathematical modeling of peripheral blood neutrophil kinetics to predict CLAD after lung transplantation.

Journal: Transplant immunology

Published: March 04, 2020

Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphoma.

Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphoma.

Journal: Leukemia & lymphoma

Published: January 05, 2020

Cancer risk in HIV-infected patients: elite controllers are also concerned.

Cancer risk in HIV-infected patients: elite controllers are also concerned.

Journal: AIDS (London, England)

Published: March 02, 2018

Genetic and Functional Profiling of CD16-Dependent Natural Killer Activation Identifies Patients at Higher Risk of Cardiac Allograft Vasculopathy.

Genetic and Functional Profiling of CD16-Dependent Natural Killer Activation Identifies Patients at Higher Risk of Cardiac Allograft Vasculopathy.

Journal: Circulation

Published: July 08, 2017

Antibody-Dependent NK Cell Activation Is Associated with Late Kidney Allograft Dysfunction and the Complement-Independent Alloreactive Potential of Donor-Specific Antibodies.

Antibody-Dependent NK Cell Activation Is Associated with Late Kidney Allograft Dysfunction and the Complement-Independent Alloreactive Potential of Donor-Specific Antibodies.

Journal: Frontiers in immunology

Published: June 17, 2016

Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial.

Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial.

Journal: Retrovirology

Published: May 11, 2016

Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial.

Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial.

Journal: Retrovirology

Published: February 01, 2016

Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.

Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.

Journal: AIDS (London, England)

Published: August 06, 2015

Characterization of the novel Sezary lymphoma cell line BKP1.

Characterization of the novel Sezary lymphoma cell line BKP1.

Journal: Experimental dermatology

Published: October 10, 2014

HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 "aging" study.

HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 "aging" study.

Journal: PloS one

Published: August 08, 2012

Lack of correlation between the size of HIV proviral DNA reservoir and the level of immune activation in HIV-infected patients with a sustained undetectable HIV viral load for 10 years.

Lack of correlation between the size of HIV proviral DNA reservoir and the level of immune activation in HIV-infected patients with a sustained undetectable HIV viral load for 10 years.

Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Published: July 04, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026